Company intelligence / Profile preview

Pioneering Medicines

Cambridge, Massachusetts, United Statesflagshippioneering.com ↗

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Pioneering Medicines has built a portfolio spanning several therapeutic areas with both internal and partnered programs. Their approach emphasizes rapid translation from concept through preclinical/early clinical stages using innovative technologies sourced from over 40 companies in the Flagship network. Clinical results are not yet broadly published as most programs are in early stages or partnered out after proof-of-concept

Therapeutic areas: GastroenterologyPulmonologyImmunologyEndocrinologyOther
Modalities: small moleculesbiologicsnovel modalities developed within the Flagship ecosystem
Industry: Biotech

Partnerships

Pfizer (strategic alliance for drug discovery/development)Novo Nordisk (innovation supply chain partnership)Cystic Fibrosis FoundationCharles River Laboratories

Beyond the preview

Go deeper on Pioneering Medicines.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pioneering Medicines.